Clinical and Experimental Pharmacology and Physiology · 2021 · 17 citations · 35 references
MedicineEndocrinologyPharmacologyInflammationMetabolic RegulationSignal TransductionAdipose TissueInsulin ResistanceLipid MetabolismMetabolic InflammationMetabolic SignalingMetabolic SyndromeAdipose Tissue DysfunctionBrown Adipose Tissue ActivationBrown Adipose Tissue MetabolismIncreased AdiposityObesity TreatmentObesity-associated Insulin ResistanceObesity-induced InflammationThiobarbituric Acid Reactive Substances
Mirabegron is a selective β₃-adrenergic receptors agonist, which has been recently shown to improve metabolic health in rodents and humans. In this study, we investigated the effects of 2-week mirabegron treatment on the metabolic parameters of mice with a diet-induced obesity (DIO). C57BL/6JUnib mice were divided into control (CTR) and obese (OB) groups treated with vehicle, and an OB group treated with mirabegron (OB + MIRA). The obese groups were fed a high-fat diet for 12 weeks. Mirabegron (10 mg/kg/day) was administrated orally by gavage from weeks 10-12. After 2 weeks of mirabegron treatment, the energy expenditure was assessed with indirect calorimetry. Blood glucose, insulin, glycerol, free fatty acids (FFA), thiobarbituric acid reactive substance (TBAR), and tumour necrosis factor (TNF)-α levels were also assessed, and the HOMA index was determined. Liver tissue, brown adipose tissue (BAT), and inguinal white adipose tissue (iWAT) samples were collected for histological examination. The protein expressions of uncoupling protein 1 (UCP1) and mitochondrial transcription factor A (TFAM) were assessed using western blotting of the BAT and iWAT samples. In this study, mirabegron increased the energy expenditure and decreased adiposity in OB + MIRA. Increased UCP1 expression in BAT without changes in iWAT was also found. Mirabegron decreased circulating levels of FFA, glycerol, insulin, TNF-α, TBARS and HOMA index. DIO significantly increased the lipid deposits in the liver and BAT, but mirabegron partially reversed this change. Our findings indicate that treatment with mirabegron decreased inflammation and improved metabolism in obese mice. This effect was associated with increased BAT-mediated energy expenditure, but not iWAT beiging, which suggests that mirabegron might be useful for the treatment of obesity and diabetes.
35
Identification and Importance of Brown Adipose Tissue in Adult Humans
Aaron M. Cypess, Sanaz Lehman, Gethin Williams et al. · New England Journal of Medicine · 2009 · 4.4K citations · Full text
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Jun Wu, Pontus Boström, Lauren M. Sparks et al. · Cell · 2012 · 3.3K citations · Full text
PRDM16 controls a brown fat/skeletal muscle switch
Patrick Seale, Bryan C. Bjork, Wenli Yang et al. · Nature · 2008 · 2.3K citations · Full text
Nataša Petrovič, Tomas B. Waldén, Irina G. Shabalina et al. · Journal of Biological Chemistry · 2009 · 1.3K citations · Full text